http://scigraph.springernature.com/pub.10.1007/s00210-018-1483-7
Pharmacological inhibition of IL-6 trans-signaling improves compromised fracture healing after severe trauma View Full Text
Kathrin Kaiser, Katja Prystaz, Anna Vikman, Melanie Haffner-Luntzer, Stephanie Bergdolt, Gudrun Strauss, Georg H. Waetzig, Stefan Rose-John, Anita Ignatius
Patients with multiple injuries frequently suffer bone fractures and are at high risk to develop fracture healing complications. Because of its key role both in systemic posttraumatic inflammation and fracture healing, the pleiotropic cytokine interleukin-6 (IL-6) may be involved in the pathomechanisms of trauma-induced compromised fracture healing. IL-6 signals are transmitted by two different mechanisms: classic signaling via the membrane-bound receptor (mIL-6R) and trans-signaling via its soluble form (sIL-6R). Herein, we investigated whether IL-6 classic and trans-signaling play different roles in bone regeneration after severe injury. Twelve-week-old C57BL/6J mice underwent combined femur osteotomy and thoracic trauma. To study the function of IL-6, either an anti-IL-6 antibody, which inhibits both IL-6 classic and trans-signaling, or a soluble glycoprotein 130 fusion protein (sgp130Fc), which selectively blocks trans-signaling, were injected 30 min and 48 h after surgery. Bone healing was assessed using cytokine analyses, flow cytometry, histology, micro-computed tomography, and biomechanical testing. Selective inhibition of IL-6 trans-signaling significantly improved the fracture healing outcome after combined injury, as confirmed by accelerated cartilage-to-bone transformation, enhanced bony bridging of the fracture gap and improved mechanical callus properties. In contrast, global IL-6 inhibition did not affect compromised fracture healing. These data suggest that classic signaling may mediate beneficial effects on bone repair after severe injury. Selective inhibition of IL-6 trans-signaling might have therapeutic potential to treat fracture healing complications in patients with concomitant injuries. More... »
2012-03. Fracture healing under healthy and inflammatory conditions in NATURE REVIEWS RHEUMATOLOGY
2015-04. Diabetes, Diabetic Complications, and Fracture Risk in CURRENT OSTEOPOROSIS REPORTS
2010-08. The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis in OSTEOPOROSIS INTERNATIONAL
2014-05. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin in NATURE IMMUNOLOGY
2016-12. Immunological characterization of the early human fracture hematoma in IMMUNOLOGIC RESEARCH
2009-12. IL-6 predicts organ dysfunction and mortality in patients with multiple injuries in SCANDINAVIAN JOURNAL OF TRAUMA, RESUSCITATION AND EMERGENCY MEDICINE
2001-06. The influence of fracture etiology and type on fracture healing: a review of 104 consecutive tibial shaft fractures in ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
2014-06. Cytokine Levels (IL-4, IL-6, IL-8 and TGFβ) as Potential Biomarkers of Systemic Inflammatory Response in Trauma Patients in INTERNATIONAL ORTHOPAEDICS
2014-08. Zytokine als Marker bei Polytrauma in DER UNFALLCHIRURG
Naunyn-Schmiedeberg's Archives of Pharmacology
FOR: Clinical Sciences
MESH: Animals
MESH: Antibodies
MESH: Cytokines
MESH: Femur
MESH: Fracture Healing
MESH: Male
MESH: Mice, Inbred C57bl
MESH: Osteotomy
MESH: Recombinant Fusion Proteins
MESH: Signal Transduction
MESH: Thoracic Injuries
MESH: Wounds And Injuries
MESH: X-Ray Microtomography
University Hospital Ulm
Conaris
Kiel University
"name": "Clinical Sciences",
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Animals",
"name": "Antibodies",
"name": "Cytokines",
"name": "Femur",
"name": "Fracture Healing",
"name": "Mice, Inbred C57BL",
"name": "Osteotomy",
"name": "Recombinant Fusion Proteins",
"name": "Signal Transduction",
"name": "Thoracic Injuries",
"name": "Wounds and Injuries",
"name": "X-Ray Microtomography",
"alternateName": "University Hospital Ulm",
"Institute of Orthopedic Research and Biomechanics, Trauma Research Center Ulm, University Medical Center Ulm, 89081, Ulm, Germany"
"familyName": "Kaiser",
"givenName": "Kathrin",
"familyName": "Prystaz",
"givenName": "Katja",
"familyName": "Vikman",
"givenName": "Anna",
"familyName": "Haffner-Luntzer",
"givenName": "Melanie",
"familyName": "Bergdolt",
"givenName": "Stephanie",
"Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, 89075, Ulm, Germany"
"familyName": "Strauss",
"givenName": "Gudrun",
"alternateName": "Conaris",
"id": "https://www.grid.ac/institutes/grid.482435.c",
"CONARIS Research Institute AG, 24118, Kiel, Germany"
"familyName": "Waetzig",
"givenName": "Georg H.",
"alternateName": "Kiel University",
"id": "https://www.grid.ac/institutes/grid.9764.c",
"Institute of Biochemistry, Christian-Albrechts-University of Kiel, 24118, Kiel, Germany"
"familyName": "Rose-John",
"givenName": "Stefan",
"familyName": "Ignatius",
"givenName": "Anita",
"id": "sg:pub.10.1038/ni.2865",
"https://doi.org/10.1038/ni.2865"
"id": "https://doi.org/10.1097/00005131-200305000-00006",
"id": "sg:pub.10.1038/nrrheum.2012.1",
"https://doi.org/10.1038/nrrheum.2012.1"
"id": "https://doi.org/10.1677/joe-08-0568",
"id": "https://doi.org/10.15252/emmm.201404487",
"id": "https://doi.org/10.1016/j.bbamcr.2011.01.034",
"id": "sg:pub.10.1007/s004020000252",
"https://doi.org/10.1007/s004020000252"
"id": "https://doi.org/10.1001/archsurg.135.3.291",
"id": "https://doi.org/10.1371/journal.pone.0116282",
"id": "sg:pub.10.1007/s00113-013-2543-6",
"https://doi.org/10.1007/s00113-013-2543-6"
"id": "https://doi.org/10.1097/bot.0b013e3181ed1361",
"id": "https://doi.org/10.1093/rheumatology/keu035",
"id": "https://doi.org/10.1016/j.injury.2007.10.003",
"id": "https://doi.org/10.1182/blood-2008-05-155846",
"id": "https://doi.org/10.1155/2016/9894716",
"id": "https://doi.org/10.1177/1753425908100016",
"id": "https://doi.org/10.1177/154405910808700215",
"id": "https://doi.org/10.4049/jimmunol.181.3.2189",
"id": "https://doi.org/10.1172/jci64931",
"id": "https://doi.org/10.7150/ijbs.4989",
"id": "https://doi.org/10.1016/j.smim.2013.11.002",
"id": "https://doi.org/10.1074/jbc.m111.295758",
"id": "https://doi.org/10.1001/jamasurg.2016.2775",
"id": "https://doi.org/10.1097/01.ccm.0000207343.53990.a8",
"id": "https://doi.org/10.1002/jor.22857",
"id": "https://doi.org/10.4049/jimmunol.0901929",
"id": "https://doi.org/10.2217/imt-2016-0020",
"id": "https://doi.org/10.1016/j.bone.2016.02.020",
"id": "https://doi.org/10.1189/jlb.0810446",
"id": "https://doi.org/10.1016/j.jhep.2016.02.004",
"id": "https://doi.org/10.1189/jlb.3a0515-207r",
"id": "sg:pub.10.1186/1757-7241-17-49",
"https://doi.org/10.1186/1757-7241-17-49"
"id": "https://doi.org/10.1097/ccm.0b013e318211ff56",
"id": "https://doi.org/10.1302/0301-620x.86b6.14176",
"id": "https://doi.org/10.1517/14728222.11.5.613",
"id": "https://doi.org/10.1359/jbmr.2001.16.6.1004",
"id": "https://doi.org/10.1097/01.shk.0000070739.34700.f6",
"id": "https://doi.org/10.1097/shk.0b013e3181d8e687",
"id": "https://doi.org/10.1002/jbmr.141",
"id": "https://doi.org/10.22203/ecm.v032a10",
"id": "https://doi.org/10.3899/jrheum.150457",
"id": "https://doi.org/10.1002/term.2593",
"id": "https://doi.org/10.1016/j.ajpath.2017.10.011",
"description": "Patients with multiple injuries frequently suffer bone fractures and are at high risk to develop fracture healing complications. Because of its key role both in systemic posttraumatic inflammation and fracture healing, the pleiotropic cytokine interleukin-6 (IL-6) may be involved in the pathomechanisms of trauma-induced compromised fracture healing. IL-6 signals are transmitted by two different mechanisms: classic signaling via the membrane-bound receptor (mIL-6R) and trans-signaling via its soluble form (sIL-6R). Herein, we investigated whether IL-6 classic and trans-signaling play different roles in bone regeneration after severe injury. Twelve-week-old C57BL/6J mice underwent combined femur osteotomy and thoracic trauma. To study the function of IL-6, either an anti-IL-6 antibody, which inhibits both IL-6 classic and trans-signaling, or a soluble glycoprotein 130 fusion protein (sgp130Fc), which selectively blocks trans-signaling, were injected 30\u00a0min and 48\u00a0h after surgery. Bone healing was assessed using cytokine analyses, flow cytometry, histology, micro-computed tomography, and biomechanical testing. Selective inhibition of IL-6 trans-signaling significantly improved the fracture healing outcome after combined injury, as confirmed by accelerated cartilage-to-bone transformation, enhanced bony bridging of the fracture gap and improved mechanical callus properties. In contrast, global IL-6 inhibition did not affect compromised fracture healing. These data suggest that classic signaling may mediate beneficial effects on bone repair after severe injury. Selective inhibition of IL-6 trans-signaling might have therapeutic potential to treat fracture healing complications in patients with concomitant injuries.",
"0028-1298",
"name": "Naunyn-Schmiedeberg's Archives of Pharmacology",
"volumeNumber": "391"
"name": "Pharmacological inhibition of IL-6 trans-signaling improves compromised fracture healing after severe trauma",
"pagination": "523-536",
"b712a43448f419128ed0a157d6bcfc7feb84f6c5091af5d34282b561faecbe22"
"0326264"
"10.1007/s00210-018-1483-7"
"https://doi.org/10.1007/s00210-018-1483-7",
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113644_00000004.jsonl",
"url": "https://link.springer.com/10.1007%2Fs00210-018-1483-7"
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00210-018-1483-7'
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00210-018-1483-7'
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00210-018-1483-7'
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00210-018-1483-7'
370 TRIPLES 21 PREDICATES 101 URIs 34 LITERALS 22 BLANK NODES
1 sg:pub.10.1007/s00210-018-1483-7 schema:about N0ff6c27e53a94d459fd46db362a81a08
2 ″ ″ N11d92c1aae9e4941922f9d5ae93e6092
3 ″ ″ N124926cf13064712ab125ba9ad835baa
4 ″ ″ N5d52d925917e4bae924ae11243e1f26a
5 ″ ″ N63b54270a4464cfcb78f0566868a75e5
6 ″ ″ N99db69218d12412681dc2000595916d8
7 ″ ″ Nb1502aee8ab4462889dc468f9e10ae14
8 ″ ″ Nbb0b9afd37d54fca8fe95393b52dbb36
9 ″ ″ Nc9c851822cb546ad97deac859171d82c
10 ″ ″ Nd6b68ea2af364554bc77cae57d2cf224
11 ″ ″ Ne0170e2e41c347fb98dbfba5d1faa909
12 ″ ″ Nf28109a669374587a2de8f3bff477dc7
13 ″ ″ Nf5c2118a956d4f70916a9f8fc01c3455
14 ″ ″ anzsrc-for:11
15 ″ ″ anzsrc-for:1103
16 ″ schema:author N5af2d2339951461ab0de19c43fcfd3b2
17 ″ schema:citation sg:pub.10.1007/s00113-013-2543-6
18 ″ ″ sg:pub.10.1007/s00198-010-1192-7
20 ″ ″ sg:pub.10.1007/s004020000252
23 ″ ″ sg:pub.10.1038/ni.2865
24 ″ ″ sg:pub.10.1038/nrrheum.2012.1
25 ″ ″ sg:pub.10.1186/1757-7241-17-49
26 ″ ″ https://doi.org/10.1001/archsurg.135.3.291
27 ″ ″ https://doi.org/10.1001/jamasurg.2016.2775
28 ″ ″ https://doi.org/10.1002/jbmr.141
29 ″ ″ https://doi.org/10.1002/jor.21148
32 ″ ″ https://doi.org/10.1002/term.2593
33 ″ ″ https://doi.org/10.1016/j.ajpath.2017.10.011
34 ″ ″ https://doi.org/10.1016/j.bbamcr.2011.01.034
36 ″ ″ https://doi.org/10.1016/j.bone.2007.07.022
39 ″ ″ https://doi.org/10.1016/j.injury.2007.10.003
41 ″ ″ https://doi.org/10.1016/j.jhep.2016.02.004
42 ″ ″ https://doi.org/10.1016/j.smim.2013.11.002
46 ″ ″ https://doi.org/10.1074/jbc.m111.295758
47 ″ ″ https://doi.org/10.1093/rheumatology/keu035
48 ″ ″ https://doi.org/10.1097/00005131-200305000-00006
49 ″ ″ https://doi.org/10.1097/01.ccm.0000207343.53990.a8
50 ″ ″ https://doi.org/10.1097/01.shk.0000070739.34700.f6
51 ″ ″ https://doi.org/10.1097/bot.0b013e3181ed1361
52 ″ ″ https://doi.org/10.1097/ccm.0b013e318211ff56
53 ″ ″ https://doi.org/10.1097/shk.0b013e3181d8e687
54 ″ ″ https://doi.org/10.1155/2016/9894716
55 ″ ″ https://doi.org/10.1172/jci64931
56 ″ ″ https://doi.org/10.1177/154405910808700215
57 ″ ″ https://doi.org/10.1177/1753425908100016
58 ″ ″ https://doi.org/10.1182/blood-2007-07-102137
60 ″ ″ https://doi.org/10.1189/jlb.0810446
61 ″ ″ https://doi.org/10.1189/jlb.3a0515-207r
62 ″ ″ https://doi.org/10.1302/0301-620x.86b6.14176
63 ″ ″ https://doi.org/10.1359/jbmr.2001.16.6.1004
64 ″ ″ https://doi.org/10.1371/journal.pone.0116282
67 ″ ″ https://doi.org/10.1517/14728222.11.5.613
68 ″ ″ https://doi.org/10.15252/emmm.201404487
69 ″ ″ https://doi.org/10.1677/joe-08-0568
70 ″ ″ https://doi.org/10.2217/imt-2016-0020
71 ″ ″ https://doi.org/10.22203/ecm.v032a10
72 ″ ″ https://doi.org/10.3899/jrheum.150457
73 ″ ″ https://doi.org/10.4049/jimmunol.0901929
74 ″ ″ https://doi.org/10.4049/jimmunol.181.3.2189
75 ″ ″ https://doi.org/10.7150/ijbs.4989
78 ″ schema:description Patients with multiple injuries frequently suffer bone fractures and are at high risk to develop fracture healing complications. Because of its key role both in systemic posttraumatic inflammation and fracture healing, the pleiotropic cytokine interleukin-6 (IL-6) may be involved in the pathomechanisms of trauma-induced compromised fracture healing. IL-6 signals are transmitted by two different mechanisms: classic signaling via the membrane-bound receptor (mIL-6R) and trans-signaling via its soluble form (sIL-6R). Herein, we investigated whether IL-6 classic and trans-signaling play different roles in bone regeneration after severe injury. Twelve-week-old C57BL/6J mice underwent combined femur osteotomy and thoracic trauma. To study the function of IL-6, either an anti-IL-6 antibody, which inhibits both IL-6 classic and trans-signaling, or a soluble glycoprotein 130 fusion protein (sgp130Fc), which selectively blocks trans-signaling, were injected 30 min and 48 h after surgery. Bone healing was assessed using cytokine analyses, flow cytometry, histology, micro-computed tomography, and biomechanical testing. Selective inhibition of IL-6 trans-signaling significantly improved the fracture healing outcome after combined injury, as confirmed by accelerated cartilage-to-bone transformation, enhanced bony bridging of the fracture gap and improved mechanical callus properties. In contrast, global IL-6 inhibition did not affect compromised fracture healing. These data suggest that classic signaling may mediate beneficial effects on bone repair after severe injury. Selective inhibition of IL-6 trans-signaling might have therapeutic potential to treat fracture healing complications in patients with concomitant injuries.
82 ″ schema:isPartOf N7d5a7538072145babc57117c95769df0
83 ″ ″ Ne7c0773b2b9f454babc96c7faeae2a11
85 ″ schema:name Pharmacological inhibition of IL-6 trans-signaling improves compromised fracture healing after severe trauma
86 ″ schema:pagination 523-536
87 ″ schema:productId N2639eaf5c7d140b8aad5d77fd5d41602
88 ″ ″ N2f0f229ca6554f22a60bd50afeb538e0
89 ″ ″ N64248eb9a70846e5a8e2276e9bf882d1
90 ″ ″ N885530a6d1974adb90195a2d8c1a78af
91 ″ ″ Nc2835b56548546ecb4488215fafa94f3
93 ″ ″ https://doi.org/10.1007/s00210-018-1483-7
96 ″ schema:sdPublisher N22bd382150e342f7814d14ffa0da6de4
97 ″ schema:url https://link.springer.com/10.1007%2Fs00210-018-1483-7
100 ″ rdf:type schema:ScholarlyArticle
101 N0ff6c27e53a94d459fd46db362a81a08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 ″ schema:name Thoracic Injuries
104 N11d92c1aae9e4941922f9d5ae93e6092 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 ″ schema:name Recombinant Fusion Proteins
107 N124926cf13064712ab125ba9ad835baa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 ″ schema:name Cytokines
110 N173f7d53870d4e2f9c22697220bcd684 rdf:first sg:person.01063054152.05
111 ″ rdf:rest Ne9b77fd0a4cd40cc87931f7b94bfcdae
112 N22bd382150e342f7814d14ffa0da6de4 schema:name Springer Nature - SN SciGraph project
114 N2639eaf5c7d140b8aad5d77fd5d41602 schema:name pubmed_id
115 ″ schema:value 29497762
117 N28c09770342e41e9800241b729ebe58b rdf:first sg:person.01112376705.20
118 ″ rdf:rest N173f7d53870d4e2f9c22697220bcd684
119 N2f0f229ca6554f22a60bd50afeb538e0 schema:name readcube_id
120 ″ schema:value b712a43448f419128ed0a157d6bcfc7feb84f6c5091af5d34282b561faecbe22
122 N4cc75f78e02b42ce8e3f2958f500f370 rdf:first sg:person.012564620705.90
123 ″ rdf:rest N28c09770342e41e9800241b729ebe58b
124 N5af2d2339951461ab0de19c43fcfd3b2 rdf:first sg:person.07416662653.47
125 ″ rdf:rest N8fe42e0f4bf945a8b28937dc22be5be0
126 N5d52d925917e4bae924ae11243e1f26a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 ″ schema:name Male
129 N63b54270a4464cfcb78f0566868a75e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 ″ schema:name Fracture Healing
132 N64248eb9a70846e5a8e2276e9bf882d1 schema:name doi
133 ″ schema:value 10.1007/s00210-018-1483-7
135 N7d5a7538072145babc57117c95769df0 schema:issueNumber 5
137 N885530a6d1974adb90195a2d8c1a78af schema:name nlm_unique_id
138 ″ schema:value 0326264
140 N8fe42e0f4bf945a8b28937dc22be5be0 rdf:first sg:person.013336716741.07
141 ″ rdf:rest Nb1241e85857c446bb2febacae7ad5932
142 N99db69218d12412681dc2000595916d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 ″ schema:name Femur
145 N9f35d3f87a914a7b967cf46bbdc9d70e rdf:first sg:person.01344307440.74
146 ″ rdf:rest rdf:nil
147 Na061b32f289041778c2c5889fc8a9579 rdf:first sg:person.01010274715.14
148 ″ rdf:rest N4cc75f78e02b42ce8e3f2958f500f370
149 Nb1241e85857c446bb2febacae7ad5932 rdf:first sg:person.012450174120.69
150 ″ rdf:rest Na061b32f289041778c2c5889fc8a9579
151 Nb1502aee8ab4462889dc468f9e10ae14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 ″ schema:name X-Ray Microtomography
154 Nbb0b9afd37d54fca8fe95393b52dbb36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 ″ schema:name Wounds and Injuries
157 Nc2835b56548546ecb4488215fafa94f3 schema:name dimensions_id
158 ″ schema:value pub.1101293645
160 Nc9c851822cb546ad97deac859171d82c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 ″ schema:name Signal Transduction
163 Nd6b68ea2af364554bc77cae57d2cf224 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 ″ schema:name Mice, Inbred C57BL
166 Ne0170e2e41c347fb98dbfba5d1faa909 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 ″ schema:name Osteotomy
169 Ne7c0773b2b9f454babc96c7faeae2a11 schema:volumeNumber 391
170 ″ rdf:type schema:PublicationVolume
171 Ne9b77fd0a4cd40cc87931f7b94bfcdae rdf:first sg:person.01070364406.83
172 ″ rdf:rest N9f35d3f87a914a7b967cf46bbdc9d70e
173 Nf28109a669374587a2de8f3bff477dc7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 ″ schema:name Animals
176 Nf5c2118a956d4f70916a9f8fc01c3455 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 ″ schema:name Antibodies
183 ″ schema:name Clinical Sciences
186 ″ ″ 1432-1912
187 ″ schema:name Naunyn-Schmiedeberg's Archives of Pharmacology
190 ″ schema:familyName Haffner-Luntzer
191 ″ schema:givenName Melanie
194 sg:person.01063054152.05 schema:affiliation https://www.grid.ac/institutes/grid.482435.c
195 ″ schema:familyName Waetzig
196 ″ schema:givenName Georg H.
199 sg:person.01070364406.83 schema:affiliation https://www.grid.ac/institutes/grid.9764.c
200 ″ schema:familyName Rose-John
201 ″ schema:givenName Stefan
205 ″ schema:familyName Strauss
206 ″ schema:givenName Gudrun
209 sg:person.012450174120.69 schema:affiliation https://www.grid.ac/institutes/grid.410712.1
210 ″ schema:familyName Vikman
211 ″ schema:givenName Anna
215 ″ schema:familyName Bergdolt
216 ″ schema:givenName Stephanie
220 ″ schema:familyName Prystaz
221 ″ schema:givenName Katja
225 ″ schema:familyName Ignatius
226 ″ schema:givenName Anita
230 ″ schema:familyName Kaiser
231 ″ schema:givenName Kathrin
234 sg:pub.10.1007/s00113-013-2543-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011063752
235 ″ ″ https://doi.org/10.1007/s00113-013-2543-6
243 sg:pub.10.1007/s004020000252 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006489388
244 ″ ″ https://doi.org/10.1007/s004020000252
252 sg:pub.10.1038/ni.2865 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000270806
253 ″ ″ https://doi.org/10.1038/ni.2865
255 sg:pub.10.1038/nrrheum.2012.1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002058201
256 ″ ″ https://doi.org/10.1038/nrrheum.2012.1
258 sg:pub.10.1186/1757-7241-17-49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045507731
259 ″ ″ https://doi.org/10.1186/1757-7241-17-49
261 https://doi.org/10.1001/archsurg.135.3.291 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009468158
263 https://doi.org/10.1001/jamasurg.2016.2775 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026561068
265 https://doi.org/10.1002/jbmr.141 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051896173
267 https://doi.org/10.1002/jor.21148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037745851
273 https://doi.org/10.1002/term.2593 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092275124
275 https://doi.org/10.1016/j.ajpath.2017.10.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092667122
277 https://doi.org/10.1016/j.bbamcr.2011.01.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004208759
281 https://doi.org/10.1016/j.bone.2007.07.022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046069521
287 https://doi.org/10.1016/j.injury.2007.10.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014716487
291 https://doi.org/10.1016/j.jhep.2016.02.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043607662
293 https://doi.org/10.1016/j.smim.2013.11.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024552895
301 https://doi.org/10.1074/jbc.m111.295758 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025754588
303 https://doi.org/10.1093/rheumatology/keu035 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011749836
305 https://doi.org/10.1097/00005131-200305000-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000508488
307 https://doi.org/10.1097/01.ccm.0000207343.53990.a8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026604140
309 https://doi.org/10.1097/01.shk.0000070739.34700.f6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047109606
311 https://doi.org/10.1097/bot.0b013e3181ed1361 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011361087
313 https://doi.org/10.1097/ccm.0b013e318211ff56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045565265
315 https://doi.org/10.1097/shk.0b013e3181d8e687 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050142666
317 https://doi.org/10.1155/2016/9894716 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015012777
319 https://doi.org/10.1172/jci64931 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020961812
321 https://doi.org/10.1177/154405910808700215 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020179899
323 https://doi.org/10.1177/1753425908100016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017782525
325 https://doi.org/10.1182/blood-2007-07-102137 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046787736
329 https://doi.org/10.1189/jlb.0810446 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038917907
331 https://doi.org/10.1189/jlb.3a0515-207r schema:sameAs https://app.dimensions.ai/details/publication/pub.1044699493
333 https://doi.org/10.1302/0301-620x.86b6.14176 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046527973
335 https://doi.org/10.1359/jbmr.2001.16.6.1004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047066836
337 https://doi.org/10.1371/journal.pone.0116282 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009976754
343 https://doi.org/10.1517/14728222.11.5.613 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046761943
345 https://doi.org/10.15252/emmm.201404487 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003777773
347 https://doi.org/10.1677/joe-08-0568 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002167433
349 https://doi.org/10.2217/imt-2016-0020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032609923
351 https://doi.org/10.22203/ecm.v032a10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069339244
353 https://doi.org/10.3899/jrheum.150457 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084858653
355 https://doi.org/10.4049/jimmunol.0901929 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031138270
357 https://doi.org/10.4049/jimmunol.181.3.2189 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020333251
359 https://doi.org/10.7150/ijbs.4989 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021655917
361 https://www.grid.ac/institutes/grid.410712.1 schema:alternateName University Hospital Ulm
362 ″ schema:name Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, 89075, Ulm, Germany
363 ″ ″ Institute of Orthopedic Research and Biomechanics, Trauma Research Center Ulm, University Medical Center Ulm, 89081, Ulm, Germany
365 https://www.grid.ac/institutes/grid.482435.c schema:alternateName Conaris
366 ″ schema:name CONARIS Research Institute AG, 24118, Kiel, Germany
368 https://www.grid.ac/institutes/grid.9764.c schema:alternateName Kiel University
369 ″ schema:name Institute of Biochemistry, Christian-Albrechts-University of Kiel, 24118, Kiel, Germany